Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 8,292 | 10,837 | 11,713 | 10,436 | 9,086 |
| Cost of Goods | 989 | 2,011 | 1,426 | 1,977 | 1,323 |
| Gross Profit | 7,304 | 8,826 | 10,287 | 8,459 | 7,763 |
| Operating Expenses | 10,258 | 9,585 | 9,421 | 11,278 | 9,780 |
| Operating Income | -1,965 | -748 | 1,292 | -1,842 | -1,694 |
| Interest Expense | 110 | 110 | 164 | 223 | 137 |
| Other Income | 132 | 128 | 126 | 107 | 306 |
| Pre-tax Income | -1,943 | -730 | 1,254 | -1,959 | -1,526 |
| Income Tax | 6 | 6 | 6 | -57 | 11 |
| Net Income Continuous | -1,949 | -735 | 1,248 | -1,902 | -1,537 |
| Minority Interests | -8 | 6 | -9 | 2 | 7 |
| Net Income | $-1,941 | $-741 | $1,257 | $-1,904 | $-1,544 |
| EPS Basic Total Ops | -0.13 | -0.05 | 0.08 | -0.13 | -0.11 |
| EPS Basic Continuous Ops | -0.13 | -0.05 | 0.08 | -0.14 | -0.11 |
| EPS Diluted Total Ops | -0.13 | -0.05 | 0.08 | -0.13 | -0.11 |
| EPS Diluted Continuous Ops | -0.13 | -0.05 | 0.08 | -0.14 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.06 | 0.02 | 0.15 | -0.03 | -0.03 |
| EBITDA(a) | $-928 | $286 | $2,324 | $-346 | $-578 |